1179615

Ascent Pharmaceuticals Inc — FEI 3009518416

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 15, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Central Islip, NY (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)

Citations

IDCFRDescription
21360FDCA 505-1(f)(4)Failure to comply with REMS Implementation System